In fact, CHK2 inactivation, which may be selected for during Myc-induced tumor progression may render cells more prone to DNA repair inhibition as shown in the case of Myc-induced tumors, where CHK2 loss shows a synergistic lethal response in combination with DNA repair inhibitors such as PARP inhibitors [45]. This evidence concerns the gene CHEK2 and neoplasm.